Who
RTW INVESTMENTS, LP
10% owner
Company insider
Files Form 4 as: 10% owner, Allurion Technologies; 10% owner, Orchestra BioMed Holdings; 10% owner, Kailera Therapeutics; Director and 10% owner and Other, Rocket Pharmaceuticals; 10% owner, CARGO Therapeutics; 10% owner, DermTech; 10% owner, Landos Biopharma; 10% owner, Milestone Pharmaceuticals.
In numbers
- Trades disclosed
- 104
- Buys
- 28
- Sells
- 6
- Bought
- $127.8M
- Sold
- $27.9M
- Companies
- 13
- Companies where not an officer
- 13
- First trade
- 16 Apr 2019
- Last trade
- 21 Jul 2026
- Last filed
- 23 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Jul 2026filed 23 Jul 2026 | Allurion TechnologiesMedical Devices | SEC FORM 4 Code J | —209,254 | filing |
| 21 Jul 2026filed 23 Jul 2026 | Allurion TechnologiesMedical Devices | SEC FORM 4 Code J | —161,807 | filing |
| 21 Jul 2026filed 23 Jul 2026 | Allurion TechnologiesMedical Devices | SEC FORM 4 Code J | —19,934 | filing |
| 21 Jul 2026filed 23 Jul 2026 | Allurion Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code J | —209,254 | filing |
| 21 Jul 2026filed 23 Jul 2026 | Allurion Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code J | —161,807 | filing |
| 21 Jul 2026filed 23 Jul 2026 | Allurion Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code J | —19,934 | filing |
| 21 Jul 2026filed 23 Jul 2026 | Allurion Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code J | —1,771 | filing |
| 21 Jul 2026filed 23 Jul 2026 | Allurion TechnologiesMedical Devices | SEC FORM 4 Code J | —1,771 | filing |
| 21 Jul 2026filed 23 Jul 2026 | Allurion Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code J | —209,254 | filing |
| 21 Jul 2026filed 23 Jul 2026 | Allurion Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code J | —161,807 | filing |
| 21 Jul 2026filed 23 Jul 2026 | Allurion Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code J | —19,934 | filing |
| 21 Jul 2026filed 23 Jul 2026 | Allurion Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code J | —1,771 | filing |
| 21 Jul 2026filed 23 Jul 2026 | Allurion TechnologiesMedical Devices | SEC FORM 4 Code J | —209,254 | filing |
| 21 Jul 2026filed 23 Jul 2026 | Allurion TechnologiesMedical Devices | SEC FORM 4 Code J | —161,807 | filing |
| 21 Jul 2026filed 23 Jul 2026 | Allurion TechnologiesMedical Devices | SEC FORM 4 Code J | —19,934 | filing |
| 21 Jul 2026filed 23 Jul 2026 | Allurion TechnologiesMedical Devices | SEC FORM 4 Code J | —1,771 | filing |
| 27 Apr 2026filed 29 Apr 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code X | $1251,250,032 at $0.0001 | filing |
| 27 Apr 2026filed 29 Apr 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Sold | $13232 at $4.13 | filing |
| 27 Apr 2026filed 29 Apr 2026 | OBIO Orchestra BioMed Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code X | $3.4M1,250,032 at $2.75 | filing |
| 27 Apr 2026filed 29 Apr 2026 | OBIO Orchestra BioMed Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code X | $3.4M1,250,032 at $2.75 | filing |
News
No headline names them, or the companies they trade most, lately.